G-Protein-Signaling Modulator 2 Expression and Role in a CD133+ Pancreatic Cancer Stem Cell Subset

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s187670
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Role of Protein Kinase D Signaling in Pancreatic Cancer

Biochemical Pharmacology
BiochemistryPharmacology
2010English

CD133 in Breast Cancer Cells: More Than a Stem Cell Marker

Journal of Oncology
Oncology
2019English

Rapid Re-Expression of CD133 Protein in Colorectal Cancer Cell Lines in Vitro and in Vivo

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2012English

Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

Stem Cell–directed Therapies in Pancreatic Cancer

Current Problems in Cancer
Cancer ResearchOncology
2013English

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway

PLoS ONE
Multidisciplinary
2016English

Cd133/Epcam Cancer Stem Cell Markers of Tumour Stage in Colorectal Cancer Cells

Journal of Tissue Science & Engineering
2015English

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling

Scientific Reports
Multidisciplinary
2015English

Regulator of G‐Protein Signaling 16 Is a Negative Modulator of Platelet Function and Thrombosis

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy